Cargando…

Regulatory T Cells in Ovarian Carcinogenesis and Future Therapeutic Opportunities

SIMPLE SUMMARY: Regulatory T cells work to suppress the response of immune cells. In ovarian cancer, tumors may exploit immune suppression to escape destruction by the immune system. We propose that targeting regulatory T cells with medications could improve ovarian cancer survival by preventing imm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cassar, Emily, Kartikasari, Apriliana E. R., Plebanski, Magdalena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688690/ https://www.ncbi.nlm.nih.gov/pubmed/36428581 http://dx.doi.org/10.3390/cancers14225488

Ejemplares similares

Elevated Interleukin-6 Levels in the Circulation and Peritoneal Fluid of Patients with Ovarian Cancer as a Potential Diagnostic Biomarker: A Systematic Review and Meta-Analysis
por: Amer, Hina, et al.
Publicado: (2021)

Potential Impact of Human Cytomegalovirus Infection on Immunity to Ovarian Tumours and Cancer Progression
por: Cox, Momodou, et al.
Publicado: (2021)

Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker
por: Kartikasari, Apriliana E. R., et al.
Publicado: (2022)

Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune system
por: Bound, Nirashaa T., et al.
Publicado: (2022)

Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis
por: Kartikasari, Apriliana E. R., et al.
Publicado: (2021)

Therapeutic Cancer Vaccines—T Cell Responses and Epigenetic Modulation
por: Kartikasari, Apriliana E. R., et al.
Publicado: (2019)

Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses
por: Kampan, Nirmala Chandralega, et al.
Publicado: (2023)

Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities
por: Zhang, Yazhuo, et al.
Publicado: (2018)

Further Understanding of High-Grade Serous Ovarian Carcinogenesis: Potential Therapeutic Targets
por: Voutsadakis, Ioannis A
Publicado: (2020)

The Development of Nanoparticles for the Detection and Imaging of Ovarian Cancers
por: Henderson, Edward, et al.
Publicado: (2021)

Ovarian Cancer Stem Cells: Role in Metastasis and Opportunity for Therapeutic Targeting
por: Zong, Xingyue, et al.
Publicado: (2019)

The Therapeutic Potential of Regulatory T Cells: Challenges and Opportunities
por: Bayati, Fatemeh, et al.
Publicado: (2021)

Therapeutic Potential of Regulatory T Cells in Preeclampsia—Opportunities and Challenges
por: Robertson, Sarah A., et al.
Publicado: (2019)

Epilepsy in Dravet Syndrome—Current and Future Therapeutic Opportunities
por: Gao, Chao, et al.
Publicado: (2023)

Regulatory miRNAs in Colorectal Carcinogenesis and Metastasis
por: Guo, Yongchen, et al.
Publicado: (2017)

MicroRNA in Ovarian Cancer: Biology, Pathogenesis, and Therapeutic Opportunities
por: Chen, San-Nung, et al.
Publicado: (2019)

Lesser-Known Molecules in Ovarian Carcinogenesis
por: Lozneanu, Ludmila, et al.
Publicado: (2015)

Epithelial–mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities
por: Huang, Zhao, et al.
Publicado: (2022)

Editorial: The Role of TNF-TNFR2 Signal in Immunosuppressive Cells and Its Therapeutic Implications
por: Chen, Xin, et al.
Publicado: (2019)

Substantially Modified Ratios of Effector to Regulatory T Cells During Chemotherapy in Ovarian Cancer Patients Return to Pre-Treatment Levels at Completion: Implications for Immunotherapy
por: Park, Anthony, et al.
Publicado: (2012)

Heat Shock Proteins and Ovarian Cancer: Important Roles and Therapeutic Opportunities
por: Hoter, Abdullah, et al.
Publicado: (2019)

Editorial: The role of TNF-TNFR2 signal in immunosuppressive cells and its therapeutic implications, volume II
por: Chen, Xin, et al.
Publicado: (2023)

Haemophilia, state of the art and new therapeutic opportunities, a regulatory perspective
por: Tomeo, Francesca, et al.
Publicado: (2021)

Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer
por: Kampan, Nirmala Chandralega, et al.
Publicado: (2015)

Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities
por: Jain, Aditi, et al.
Publicado: (2021)

Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells
por: Kampan, Nirmala Chandralega, et al.
Publicado: (2017)

Repair and regeneration: opportunities for carcinogenesis from tissue stem cells
por: Perryman, Scott V, et al.
Publicado: (2006)

The Role of the Receptor Tyrosine Kinase Axl in Carcinogenesis and Development of Therapeutic Resistance: An Overview of Molecular Mechanisms and Future Applications
por: Wium, Martha, et al.
Publicado: (2021)

Paradoxes in carcinogenesis: New opportunities for research directions
por: Baker, Stuart G, et al.
Publicado: (2007)

Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis
por: Li, Jie, et al.
Publicado: (2012)

Mitophagy in carcinogenesis, drug resistance and anticancer therapeutics
por: Guan, Yanjie, et al.
Publicado: (2021)

Lessons, Challenges and Future Therapeutic Opportunities for PI3K Inhibition in CLL
por: Guarente, Valerio, et al.
Publicado: (2021)

Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities
por: Arias-Pinilla, Gustavo A., et al.
Publicado: (2021)

DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities
por: Ovejero-Sánchez, María, et al.
Publicado: (2023)

Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities
por: Rodrigues, Emily, et al.
Publicado: (2018)

Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects
por: Liras, Antonio
Publicado: (2010)

Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects
por: Li, Chunxiao, et al.
Publicado: (2020)

Targeting Cancer Stem Cells as the Key Driver of Carcinogenesis and Therapeutic Resistance
por: Eid, Refaat A., et al.
Publicado: (2023)

Tumor Growth Dynamic Modeling in Oncology Drug Development and Regulatory Approval: Past, Present, and Future Opportunities
por: Al‐Huniti, Nidal, et al.
Publicado: (2020)

Multifactorial carcinogenesis: implications for regulatory practice.
por: Higginson, J
Publicado: (1983)

Cannot write session to /tmp/vufind_sessions/sess_g7kpqod0lm2kfpr2i9ogogun46